TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
GOSS

Gossamer Bio Inc

Healthcare · Biotechnology

10.90$ -0.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement GOSS
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – 100.0% 100.0%
– – – – – – – – 3.6% 2.1%
– – – – – – – – 100.0% 97.9%
– – – – – – – – 120.7% 359.2%
– – – – – – – – 31.5% 77.6%
– – – – – – – – 152.2% 434.7%
– – – – – – – – -52.2% -336.8%
– – – – – – – – 10.0% 22.7%
– – – – – – – – -48.5% -351.7%
– – – – – – – – 0.8% -0.2%
– – – – – – – – -49.3% -351.5%
– – – – – – – – -34.8% -326.9%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?